IL177938A0 - Pharmaceutical preparation containing drospirenone for application to the sking - Google Patents

Pharmaceutical preparation containing drospirenone for application to the sking

Info

Publication number
IL177938A0
IL177938A0 IL177938A IL17793806A IL177938A0 IL 177938 A0 IL177938 A0 IL 177938A0 IL 177938 A IL177938 A IL 177938A IL 17793806 A IL17793806 A IL 17793806A IL 177938 A0 IL177938 A0 IL 177938A0
Authority
IL
Israel
Prior art keywords
drospirenone
application
pharmaceutical preparation
preparation containing
sking
Prior art date
Application number
IL177938A
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of IL177938A0 publication Critical patent/IL177938A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a pharmaceutical preparation containing drospirenone for application to the skin. The amount of drospirenone contained in said preparation in an initial state does not exceed saturation solubility. However, one the preparation is applied to the skin, the saturation solubility of drospirenone is exceeded. The pharmaceutical preparation enables inter alia transdermal application of contraceptively effective amounts of drospirenone.
IL177938A 2004-04-01 2006-09-07 Pharmaceutical preparation containing drospirenone for application to the sking IL177938A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004016779A DE102004016779A1 (en) 2004-04-01 2004-04-01 Drospirenone-containing preparations for transdermal use
PCT/EP2005/002971 WO2005097196A2 (en) 2004-04-01 2005-03-19 Pharmaceutical preparation containing drospirenone for application to the skin

Publications (1)

Publication Number Publication Date
IL177938A0 true IL177938A0 (en) 2006-12-31

Family

ID=34977050

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177938A IL177938A0 (en) 2004-04-01 2006-09-07 Pharmaceutical preparation containing drospirenone for application to the sking

Country Status (17)

Country Link
EP (1) EP1729778B1 (en)
JP (1) JP2007530615A (en)
KR (1) KR100832157B1 (en)
CN (1) CN1933843A (en)
AT (1) ATE397935T1 (en)
AU (1) AU2005231582A1 (en)
BR (1) BRPI0509585A (en)
CA (1) CA2558349A1 (en)
CR (1) CR8632A (en)
DE (2) DE102004016779A1 (en)
EA (1) EA200601818A1 (en)
EC (1) ECSP066900A (en)
ES (1) ES2307154T3 (en)
IL (1) IL177938A0 (en)
NO (1) NO20064978L (en)
WO (1) WO2005097196A2 (en)
ZA (1) ZA200609079B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1954240A2 (en) * 2005-07-15 2008-08-13 Bayer Schering Pharma Aktiengesellschaft Drospirenone containing transdermal drug delivery devices and methods of delivery thereof
US9050293B2 (en) 2008-07-16 2015-06-09 Juventio, Llc Small molecule solubilization system
JP6180930B2 (en) * 2010-06-16 2017-08-16 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル Methods and compositions for stimulating reepithelialization during wound healing processes
CN108606963B (en) * 2017-12-27 2021-05-18 上海长海医院 Compound contraceptive patch containing drospirenone and estrogen, preparation method and application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU610839B2 (en) * 1986-11-07 1991-05-30 Purepac, Inc Transdermal administration of amines
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
DE19651000A1 (en) * 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
DE19906152B4 (en) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Active substance-containing laminates for transdermal systems
KR20040104632A (en) * 2002-04-26 2004-12-10 쉐링 악티엔게젤샤프트 Treatment of Hypertension in Women Receiving Hormone Replacement Therapy

Also Published As

Publication number Publication date
ZA200609079B (en) 2009-04-29
EA200601818A1 (en) 2007-04-27
JP2007530615A (en) 2007-11-01
DE502005004403D1 (en) 2008-07-24
EP1729778B1 (en) 2008-06-11
ATE397935T1 (en) 2008-07-15
AU2005231582A1 (en) 2005-10-20
CR8632A (en) 2007-06-06
CN1933843A (en) 2007-03-21
KR100832157B1 (en) 2008-05-23
ES2307154T3 (en) 2008-11-16
DE102004016779A1 (en) 2006-01-19
KR20060132983A (en) 2006-12-22
WO2005097196A2 (en) 2005-10-20
NO20064978L (en) 2006-10-31
ECSP066900A (en) 2006-12-20
WO2005097196A3 (en) 2006-06-01
CA2558349A1 (en) 2005-10-20
EP1729778A2 (en) 2006-12-13
BRPI0509585A (en) 2007-10-09

Similar Documents

Publication Publication Date Title
TW200626068A (en) Active compounds for seed treatment
ZA200703002B (en) Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
TW200716183A (en) Parakeratosis inhibitor, pore-contracting agent and external composition for skin
TW200740429A (en) Methods and dosage forms for reducing side effects of carbamate compounds
TW200724166A (en) Wrinkle-improving agent
TW200716184A (en) Inhibitor for parakeratosis, pore reducing agent or skin roughening preventing or ameliorating agent and composition for skin care preparation
IL192103A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
ATE505083T1 (en) FUNGICIDAL MIXTURES
IL177938A0 (en) Pharmaceutical preparation containing drospirenone for application to the sking
WO2010075287A3 (en) Compounds and methods for the treatment of pain and other diseases
WO2002036129A3 (en) Topical treatment of mastalgia with arometese inhibitors such as androstendione
BRPI0519006A2 (en) use of a fbpase inhibitor, kit of a pharmaceutical composition, use of a biguanide preparation and a fbpase inhibitor, therapeutic agent for diabetes mellitus, and combination of therapeutic agents
TW200501957A (en) Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin Ⅱ antagonist for stroke prevention
HK1111924A1 (en) Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient
MXPA05008347A (en) Compositon comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis.
WO2008125771A3 (en) Cosmetic use of a debaryomyces hansenii extract
WO2009048746A3 (en) Self-tanning cosmetic compositions and methods
WO2005082336A3 (en) Kit comprising a plaster that optionally contains an active ingredient and an agent that prevents skin irritation
WO2009075838A3 (en) Treatment of menorrhagia with aromatase inhibitor
WO2009044787A1 (en) Remedy for tendon rupture disease comprising tenomodulin as the active ingredient
TW200735880A (en) Medicinal compositions for preventing or treating heart failure
WO2008000454A8 (en) Composition for the treatment of skin comprising ink sack liquid of cephalopods
ATE444072T1 (en) PREVENTION OF EPITHELIAL CELL CARCINOMA
LT2003089A (en) Novel use of trijodothyronine
JO2608B1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression